Join RMI² for a holiday business networking event at the December Innovation After Hours. A special graduation ceremony will also take place for Inviragen, an incubated company that is leaving RMI² after three years. Inviragen develops vaccines to fight global infectious diseases. Congratulations to Dan Stinchcomb and company! RSVP at www.rmi2.org.